232 related articles for article (PubMed ID: 22975835)
1. Long-term follow-up results of multimodal treatment with initial surgical approach for acromegaly in a single center.
Van Rompaey K; Unuane D; Moens M; Duerinck J; Poppe K; Velkeniers B; D'Haens J
Acta Neurol Belg; 2013 Mar; 113(1):49-54. PubMed ID: 22975835
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
3. The place of pegvisomant in the acromegaly treatment algorithm.
Paisley AN; Trainer PJ; Drake WM
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S101-6. PubMed ID: 15135788
[TBL] [Abstract][Full Text] [Related]
4. Recent results of secondary transnasal surgery for residual or recurring acromegaly.
Abe T; Lüdecke DK
Neurosurgery; 1998 May; 42(5):1013-21; discussion 1021-2. PubMed ID: 9588545
[TBL] [Abstract][Full Text] [Related]
5. Giant GH-secreting pituitary adenomas: management of rare and aggressive pituitary tumors.
Shimon I; Jallad RS; Fleseriu M; Yedinak CG; Greenman Y; Bronstein MD
Eur J Endocrinol; 2015 Jun; 172(6):707-13. PubMed ID: 25792375
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of pituitary adenomas].
Mezosi E; Nemes O
Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
[TBL] [Abstract][Full Text] [Related]
7. The treatment algorithm of acromegaly.
Colao A; Pivonello R; Cappabianca P; Vitale G; Lombardi G
J Endocrinol Invest; 2003; 26(8 Suppl):39-45. PubMed ID: 15233211
[No Abstract] [Full Text] [Related]
8. [Epidemiology of acromegaly in Spain].
Sesmilo G
Endocrinol Nutr; 2013 Oct; 60(8):470-4. PubMed ID: 23246411
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic management of acromegaly].
Metzner C; Hadziselimovic S; Grafe I; Nawroth P; Kasperk C
Med Klin (Munich); 2006 Jan; 101(1):15-23. PubMed ID: 16418810
[TBL] [Abstract][Full Text] [Related]
10. Multimodality treatment of pituitary adenomas.
Oyesiku NM
Clin Neurosurg; 2005; 52():234-42. PubMed ID: 16626076
[No Abstract] [Full Text] [Related]
11. Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center.
Bacigaluppi S; Gatto F; Anania P; Bragazzi NL; Rossi DC; Benvegnu G; Nazzari E; Spaziante R; Giusti M; Ferone D; Zona G
Endocrine; 2016 Mar; 51(3):524-33. PubMed ID: 25982150
[TBL] [Abstract][Full Text] [Related]
12. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
Biermasz NR; van Dulken H; Roelfsema F
J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
[TBL] [Abstract][Full Text] [Related]
13. Current treatment guidelines for acromegaly.
Melmed S; Jackson I; Kleinberg D; Klibanski A
J Clin Endocrinol Metab; 1998 Aug; 83(8):2646-52. PubMed ID: 9709926
[TBL] [Abstract][Full Text] [Related]
14. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.
Freda PU; Wardlaw SL; Post KD
J Neurosurg; 1998 Sep; 89(3):353-8. PubMed ID: 9724106
[TBL] [Abstract][Full Text] [Related]
15. Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trials.
Jimenez C; Burman P; Abs R; Clemmons DR; Drake WM; Hutson KR; Messig M; Thorner MO; Trainer PJ; Gagel RF
Eur J Endocrinol; 2008 Nov; 159(5):517-23. PubMed ID: 18708436
[TBL] [Abstract][Full Text] [Related]
16. Aftercare in patients with Cushing's disease and acromegaly: is there room for improvement?
Psaras T; Milian M; Hattermann V; Gallwitz B; Freiman T; Honegger J
Acta Neurochir (Wien); 2010 Feb; 152(2):271-8. PubMed ID: 19911113
[TBL] [Abstract][Full Text] [Related]
17. [Novel pharmacologic therapies in acromegaly].
Góth M; Hubina E; Kovács L; Szabolcs I
Orv Hetil; 2002 May; 143(19 Suppl):1057-62. PubMed ID: 12063860
[TBL] [Abstract][Full Text] [Related]
18. Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center.
Duan L; Zhu H; Xing B; Gu F
BMC Endocr Disord; 2017 Sep; 17(1):55. PubMed ID: 28874187
[TBL] [Abstract][Full Text] [Related]
19. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
Plöckinger U; Quabbe HJ
Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
[TBL] [Abstract][Full Text] [Related]
20. McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patients.
Galland F; Kamenicky P; Affres H; Reznik Y; Pontvert D; Le Bouc Y; Young J; Chanson P
J Clin Endocrinol Metab; 2006 Dec; 91(12):4957-61. PubMed ID: 16984995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
